Eclipsebio

Eclipsebio company information, Employees & Contact Information

Explore related pages

Related company profiles:

Eclipsebio develops first-in-class technologies, analyses, and platforms for the development of tomorrow’s RNA-based and RNA-targeting therapies. With our extensive experience in supporting early-stage basic research to evaluating preclinical vaccines and gene therapies, we provide unparalleled support for obtaining deep insights into RNA and therapeutic biology. We offer our solutions as end-to-end partnerships, including custom assay development, for biopharma and biotech companies and as a la carte services. Our areas of support include: - The optimization and characterization of RNA-based vaccines and therapeutics through our eMERGE platform - Multiomic characterization of small molecule and small oligonucleotide targets - Robust validation of on-target, and the identification of off-target, effects from small molecule and small oligonucleotide drugs - Deep profiling of RNA for groundbreaking discoveries in academic research Contact us today to discover how we can provide you with the insights needed for RNA success.
Looking for a particular Eclipsebio employee's phone or email?

Eclipsebio Questions

News

Webinar: The Future of mRNA Medicine: How Advanced Data Empowers Cures - BioSpace

Webinar: The Future of mRNA Medicine: How Advanced Data Empowers Cures BioSpace

Eclipsebio Launches eMERGE™ Platform, a Cutting-Edge End-to-End Solution for the Characterization and Optimization of RNA-Based Therapeutic Products - Business Wire

Eclipsebio Launches eMERGE™ Platform, a Cutting-Edge End-to-End Solution for the Characterization and Optimization of RNA-Based Therapeutic Products Business Wire

The mRNA Revolution You Haven't Heard About: From Cystic Fibrosis to Personalized Cancer Vaccines - BioSpace

The mRNA Revolution You Haven't Heard About: From Cystic Fibrosis to Personalized Cancer Vaccines BioSpace

Eclipsebio Announces a $14 Million Series A Financing to Advance Its RNA Genomics Technology Platform - PR Newswire

Eclipsebio Announces a $14 Million Series A Financing to Advance Its RNA Genomics Technology Platform PR Newswire

Beyond Black Box: How Data-Driven AI Is Transforming RNA Medicine Development - BioSpace

Beyond Black Box: How Data-Driven AI Is Transforming RNA Medicine Development BioSpace

Top Eclipsebio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant